National Bank of Canada’s Zosano Pharma Corporation ZSAN Stock Holding History

National Bank of Canada’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-280	Closed	-$2K	–	3108
2022 Q1	$2K	Buy	+280	New	+$3.08K	﹤0.01%	2752

Other funds holding ZSAN

CDIA

Capital Directions Investment Advisors Atlanta, Georgia $268M AUM 20.15% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

National Bank of Canada's ZSAN Position: Q2 2022 in Review

National Bank of Canada sold out of Zosano Pharma Corporation (ZSAN) in Q2 2022, closing a stake of 280 shares — an estimated $2K sold.

National Bank of Canada first reported a position in ZSAN in Q1 2022 and held it in 1 quarter. The position peaked at $2K in Q1 2022. 3 funds tracked by Wall St. Rank hold ZSAN as of Q2 2022.

National Bank of Canada reported no remaining Zosano Pharma Corporation position as of Q2 2022 after selling out during the quarter.
National Bank of Canada sold 280 Zosano Pharma Corporation shares in Q2 2022, an estimated $2K.
National Bank of Canada first reported a position in Zosano Pharma Corporation in Q1 2022 and held it in 1 quarter.
National Bank of Canada's Zosano Pharma Corporation position peaked at $2K in Q1 2022.
3 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2022.

Based on National Bank of Canada's 13F filing for Q2 2022, filed 28 Jul 2022.